ABN AMRO Bank N.V.

Bank

Position in LLY — ELI LILLY & Co

CIK 1561082 AMSTERDAM, P7

Position in LLY

as of Mar 31, 2026 · filed Apr 22, 2026 Compact

Position Value

$220,468,869

-$47,179,135 QoQ

Shares Held

239,700

-3.8% QoQ

Ownership

0.025%

of shares outstanding

% of Portfolio

2.44%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

ABN AMRO Bank N.V. holds $948,098,619 across 8 Drug Manufacturers - General names. LLY ranks #2 (23.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	2,445,171	$482,236,624
2	LLY	ELI LILLY & Co This page	239,700	$220,468,869
3	ABBV	AbbVie Inc.	864,389	$187,995,963
4	GILD	Gilead Sciences, Inc.	195,724	$27,278,053
5	MRK	Merck & Co., Inc.	147,377	$17,727,979
6	JNJ	Johnson & Johnson	37,023	$9,049,902
7	AMGN	Amgen Inc	5,506	$1,937,286
8	PFE	Pfizer Inc	49,998	$1,403,943

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$220,468,869	239,700	-3.8%	Shares	Sole	2026-04-22
2025-12-31	$267,648,004	249,049	+20.9%	Shares	Sole	2026-02-04
2025-09-30	$157,212,335	206,045	+2.6%	Shares	Sole	2025-11-05
2025-06-30	$156,606,797	200,899	+0.9%	Shares	Sole	2025-08-12
2025-03-31	$164,441,158	199,103	+2228.4%	Shares	Sole	2025-08-28
2024-12-31	$6,601,372	8,551	+88.0%	Shares	Sole	2025-08-28
2024-09-30	$4,030,141	4,549	+500.1%	Shares	Sole	2025-08-28
2024-06-30	$686,278	758	-19.2%	Shares	Sole	2025-08-28
2024-03-31	$729,726	938	-41.1%	Shares	Sole	2025-08-28
2023-12-31	$928,591	1,593	-30.5%	Shares	Sole	2025-08-28
2023-09-30	$1,231,639	2,293	-9.1%	Shares	Sole	2025-08-28
2023-06-30	$1,183,236	2,523	-3.7%	Shares	Sole	2025-08-28
2023-03-31	$899,760	2,620	—	Shares	Sole	2025-08-28
No filing history on record for this holder in this stock.